Seroprevalence of human herpes viruses in France, 2018–2022: a multilevel regression and poststratification approach-Reference-Cited by-同舟云学术

Seroprevalence of human herpes viruses in France, 2018–2022: a multilevel regression and poststratification approach

Published:2024-07 Issue: Volume: Page:1-15
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Supplisson Olivier¹²,Visseaux Benoit³,Haim-Boukobza Stéphanie⁴,Boutolleau David⁵⁶,Alizon Samuel¹,Burrel Sonia⁷⁸,Sofonea Mircea T.⁹

Affiliation:

1. Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France

2. Sorbonne Université, Paris, France

3. Laboratoire Cerba, pole infectiologie, Frépillon, France

4. Cerba Health Care, Issy-les-Moulineaux, France

5. AP-HP, Sorbonne Université, Centre National de Référence Herpèsvirus (laboratoire Associé), Service de Virologie, Hôpital Pitié-Salpêtrière, Paris, France

6. Sorbonne Université, INSERM UMR-S 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Paris, France

7. CHU de Bordeaux, Service de virologie, Bordeaux, France

8. CNRS UMR 5234, Fundamental Microbiology and Pathogenicity, Université de Bordeaux, Bordeaux, France

9. Pathogenesis and Control of Chronic and Emerging Infections (PCCEI), Université de Montpellier, Inserm, EFS, Montpellier, France and CHU de Nîmes, Nîmes, France

Funder

ANRS | Maladies infectieuses émergentes

Insmi/CNRS

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2024.2365906

Reference72 articles.

1. Herpesviruses

2. Prevention and control of herpesvirus diseases. Part 1. Clinical and laboratory diagnosis and chemotherapy. A WHO meeting;World Health Organisation;Bull World Health Organ,1985

3. Prevention and control of herpesvirus diseases. Part 2. Epidemiology and immunology;World Health Organisation;Bull World Health Organ,1985

4. Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data

5. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy